CHEIROARTHROPATHY AND LONG-TERM DIABETIC COMPLICATIONS IN NIGERIANS

被引:13
|
作者
AKANJI, AO [1 ]
BELLA, AF [1 ]
OSOTIMEHIN, BO [1 ]
机构
[1] UNIV IBADAN, COLL MED, DEPT MED, IBADAN, NIGERIA
关键词
D O I
10.1136/ard.49.1.28
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two hundred and fifty six consecutively ambulant diabetic patients attending a Nigerian diabetic clinic for the presence of cheiroarthropathy were examined using standard criteria. Forty eight (19%) had limited joint mobility of the hand, a prevalence higher than the 4% (2/56) observed in a non-diabetic population matched for age and sex. Limited joint mobility was twice as prevalent in the insulin treated (16/50, 32%) than in the non-insulin dependent (32/206, 16%) diabetics. Indices such as age, duration of diabetes, and glycaemic control (as assessed by integrated blood glucose concentration over the previous 12 months and glycated haemoglobin (HbA(1c) concentrations) were the same in the diabetics with and without limited joint mobility. The prevalence of cataracts (18/48, 38%) and background retinopathy (8/48, 17%) was higher in diabetics with limited joint mobility than in those without (respectively 6-9% and 5-6%); hypertension, peripheral neuropathy, and foot ulcers, however, were about equally common in the two groups of diabetics (with and without limited joint mobility). Nephropathy appeared commoner in diabetic subjects without limited joint mobility. Our results confirm previous observations in Caucasians of an increased prevalence of limited joint mobility in diabetes, especially those receiving insulin treatment, and also showed that limited joint mobility could predict the presence of retinopathy and cataracts in those diabetics. Neuropathy and hypertension were not commoner in our diabetics with limited joint mobility (unlike in the Caucasian population), suggesting that racial factors may underlie the predictive value of limited joint mobility in diabetic microangiopathy.
引用
收藏
页码:28 / 30
页数:3
相关论文
共 50 条
  • [31] Oxidative stress indices in IDDM subjects with and without long-term diabetic complications
    VanderJagt, DJ
    Harrison, JM
    Ratliff, DM
    Hunsaker, LA
    Vander Jagt, DL
    CLINICAL BIOCHEMISTRY, 2001, 34 (04) : 265 - 270
  • [32] LONG-TERM STRICT CONTROL IN IDDM-EFFECT ON LATE DIABETIC COMPLICATIONS
    DAHLJORGENSEN, K
    HANSSEN, KF
    HANSEN, OB
    DIABETES, 1983, 32 : A68 - A68
  • [33] MRI of diabetic cheiroarthropathy
    Khanna, Geetika
    Ferguson, Polly
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (01) : W94 - W95
  • [34] RESOLUTION OF DIABETIC CHEIROARTHROPATHY
    LISTER, DM
    GRAHAMBROWN, RAC
    BURDEN, AC
    BRITISH MEDICAL JOURNAL, 1986, 293 (6561): : 1537 - 1537
  • [35] JUVENILE DIABETIC CHEIROARTHROPATHY
    BENEDETTI, A
    NOACCO, C
    ACTA DIABETOLOGICA LATINA, 1976, 13 (1-2): : 54 - +
  • [36] Influence of long-term pancreatic islet graft function on development of late diabetic complications
    Várkonyi, TT
    Lengyel, C
    Fülüp, Z
    Kempler, P
    Farkas, G
    Lonovics, J
    DIABETOLOGIA, 1998, 41 : A6 - A6
  • [37] Prognostic Implications of Diabetic Ketoacidosis on Long-Term Mortality and Diabetes-Related Complications
    Budhram, Dalton R.
    Bapat, Priya
    Bakhsh, Abdulmohsen M. K.
    Abuabat, Mohammad I.
    Verhoeff, Natasha
    Mumford, Doug
    Orszag, Andrej
    Jain, Akshay B.
    Fralick, Michael
    Weisman, Alanna
    Lovblom, Leif Erik
    Perkins, Bruce A.
    DIABETES, 2024, 73
  • [38] Retrospective analysis of long-term hemorheologic effects of pentoxifylline in diabetic patients with angiopathic complications
    Solerte, SB
    Fioravanti, M
    Cerutti, N
    Severgnini, S
    Locatelli, M
    Pezza, N
    Rondanelli, M
    Trecate, L
    Balza, G
    Ferrari, E
    ACTA DIABETOLOGICA, 1997, 34 (02) : 67 - 74
  • [39] Do advanced glycation end products contribute to the development of long-term diabetic complications?
    Pugliese, Giuseppe
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (07) : 457 - 460
  • [40] New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications
    Costantino, L
    Rastelli, G
    Cignarella, G
    Vianello, P
    Barlocco, D
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (08) : 843 - 858